Publication: Lack of a synergistic effect of arginine-glutamic acid on the physical stability of spray-dried bovine serum albumin
| dc.contributor.authors | Reslan, Mouhamad; Demir, Yusuf K.; Trout, Bernhardt L.; Chan, Hak-Kim; Kayser, Veysel | |
| dc.date.accessioned | 2022-03-12T22:23:50Z | |
| dc.date.accessioned | 2026-01-11T15:08:48Z | |
| dc.date.available | 2022-03-12T22:23:50Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Improving the physical stability of spray-dried proteins is essential for enabling pulmonary delivery of biotherapeutics as a noninvasive alternative to injections. Recently, a novel combination of two amino acids - l-arginine (l-Arg) and l-glutamic acid (l-Glu), has been reported to have synergistic protein-stabilizing effects on various protein solutions. Using spray-dried bovine serum albumin (BSA) reconstituted in solution as a model protein, we investigated the synergistic effect of these amino acids on the physical stability of proteins. Five BSA solutions were prepared: (1) BSA with no amino acids (control); (2) with 50mM l-Arg; (3) with 200mM l-Arg, (4) with 50mM l-Glu and (5) with 25:25mM of Arg:Glu. All solutions were spray-dried and accelerated studies at high temperatures were performed. Following accelerated studies, monomer BSA loss was measured using SE-HPLC. We found that l-Arg significantly improved the physical stability of spray-dried BSA even at low concentrations, however, when combined with l-Glu, was ineffective at reducing monomer BSA loss. Our findings demonstrate the limitations in using Arg-Glu for the stabilization of spray-dried BSA. Furthermore, we found that a low concentration of l-Glu enhanced monomer BSA loss. These findings may have significant implications on the design of future biotherapeutic formulations. | |
| dc.identifier.doi | 10.1080/10837450.2016.1185116 | |
| dc.identifier.eissn | 1097-9867 | |
| dc.identifier.issn | 1083-7450 | |
| dc.identifier.pubmed | 27194596 | |
| dc.identifier.uri | https://hdl.handle.net/11424/234578 | |
| dc.identifier.wos | WOS:000404371600011 | |
| dc.language.iso | eng | |
| dc.publisher | TAYLOR & FRANCIS LTD | |
| dc.relation.ispartof | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Amino acids | |
| dc.subject | excipients | |
| dc.subject | physical stability | |
| dc.subject | protein aggregation | |
| dc.subject | spray-drying | |
| dc.subject | AMINO-ACIDS | |
| dc.subject | PROTEIN SOLUBILITY | |
| dc.subject | DELIVERY | |
| dc.subject | STABILIZATION | |
| dc.subject | AGGREGATION | |
| dc.subject | CHALLENGES | |
| dc.subject | STRATEGIES | |
| dc.subject | MIXTURES | |
| dc.title | Lack of a synergistic effect of arginine-glutamic acid on the physical stability of spray-dried bovine serum albumin | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 791 | |
| oaire.citation.issue | 6 | |
| oaire.citation.startPage | 785 | |
| oaire.citation.title | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | |
| oaire.citation.volume | 22 |
